Application of sr-a as a diagnostic marker and intervention target for rheumatoid arthritis
A technology of arthritis and markers, applied in the field of clinical medicine, to achieve the effects of improving detection accuracy, good diagnostic specificity, and good therapeutic effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment l
[0029] Embodiment 1 SR-A is used as the sensitivity and the specificity of marker diagnosis RA
[0030] Based on enzyme-linked immunosorbent assay (i.e., ELISA method), antibodies that specifically recognize class A scavenger receptor proteins (mouse anti-human SR-A monoclonal antibody and HRP-labeled rabbit anti-human SR-A monoclonal antibody, purchased from Beijing Yiqiao Shenzhou Biotechnology Co., Ltd.) and class A scavenger receptor protein standard (Recombinant Human SR-A, American R&D company) were used as diagnostic reagents for RA, osteoarthritis, systemic lupus erythematosus, Sjogren's syndrome and SR-A in normal human serum is detected to evaluate the distribution of SR-A in various diseases and its value in diagnosing RA.
[0031] The reagent combination used to detect the concentration of SR-A protein in the subject's serum sample includes the following components: a class A scavenger receptor protein standard, a capture antibody (capture) that binds to a microtit...
Embodiment 2
[0053] The neutralizing antibody of embodiment 2SR-A inhibits the differentiation of RA monocytes to osteoclasts
[0054] Through in vitro osteoclast induction experiments, the inhibitory effect of SR-A neutralizing antibody on osteoclastogenesis was detected, and the potential value of SR-A as an RA intervention target was evaluated.
[0055] Aseptically isolate PBMC (peripheral blood mononuclear cells) from patients with rheumatoid arthritis, and spread them into 12-well cell culture plates (5×10 5 Cells / well), change the medium after two hours of adherence, keep only the adherent monocytes (osteoclast precursor cells), and add 30ng / mL M-CSF (macrophage colony-stimulating factor) and 25ng / mL ml of RANKL (receptor activator of nuclear factor kappa B ligand).
[0056] 2μg / mL anti-SR-A neutralizing antibody (Mouse anti-human SR-A Neutralization Antibody, American R&D Company) and isotype antibody (Mouse IgG1, American R&D Company) were added to two wells of cells from the same...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com